Depression Treatment Options: Therapy, Medication, or Both?

Roughly 21 million American adults experienced a major depressive episode last year — about 8 percent of the population. Depression is one of the most treatable conditions in primary care, yet many patients spend months or years on medications that are not working, or never get past the difficulty of starting treatment. This guide covers how depression is diagnosed, what the evidence-based treatment options actually look like, and what your first visit with a telehealth provider should cover.

Understanding Depression: More Than Sadness

Clinical depression is not the same as feeling sad or having a bad week. The DSM-5 diagnosis of major depressive disorder requires five or more symptoms most of the day, nearly every day, for at least two weeks, with one of them being depressed mood or loss of interest. Symptoms include:

• Persistent sad, empty, or hopeless mood
• Marked loss of interest or pleasure in activities (anhedonia)
• Significant weight or appetite change
• Sleep disturbance — insomnia or hypersomnia
• Psychomotor agitation or slowing
• Fatigue or loss of energy
• Feelings of worthlessness or excessive guilt
• Difficulty concentrating or making decisions
• Recurrent thoughts of death or suicide

Several subtypes exist: persistent depressive disorder (a chronic, lower-intensity depression lasting two or more years), postpartum depression, seasonal affective disorder, and depression with anxious distress — the most common presentation, where anxiety and depression travel together.

First-Line Treatment: Therapy, Medication, or Both?

Per the American College of Physicians and APA guidelines, first-line treatment for mild to moderate depression is either evidence-based psychotherapy or a second-generation antidepressant (typically an SSRI). For moderate to severe depression, the combination of both produces better outcomes than either alone.

Psychotherapy. The two best-evidenced types are cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). Both are time-limited (typically 12 to 20 sessions), structured, and effective. They work as well as medications for many patients with mild to moderate depression and produce more durable results.

Medication. Antidepressants take 4 to 6 weeks to reach full effect. Most patients notice some improvement by week 2 to 4, but the decision to switch or augment should not be made before 6 weeks at an adequate dose. About 50 to 60 percent of patients respond to their first SSRI; another 20 to 30 percent respond to a different one. Treatment is typically continued for 6 to 12 months after remission to reduce relapse risk.

SSRIs — the First-Line Medication Class

Selective serotonin reuptake inhibitors are the most commonly prescribed antidepressants. They have similar efficacy to each other but differ in side effects, drug interactions, and half-life. Innocre commonly prescribes:

• Sertraline (Zoloft) 50–200 mg. Well-tolerated, few drug interactions. A common first choice. Starts at 25–50 mg and titrates up over 4–6 weeks.
• Escitalopram (Lexapro) 5–20 mg. Cleaner side-effect profile than older SSRIs. Slightly more efficacious than citalopram per meta-analyses.
• Fluoxetine (Prozac) 20–80 mg. Long half-life means missed doses matter less and discontinuation symptoms are rare. Activating — better for patients with low energy than anxiety-dominant presentations.
• Citalopram (Celexa) 20–40 mg. Older but still useful. Dose-dependent QT prolongation limits use above 40 mg in most patients.

Common SSRI side effects in the first 2–4 weeks: nausea, headache, insomnia, sexual dysfunction (reduced libido, delayed orgasm), and a paradoxical worsening of anxiety. Most physical side effects fade by week 4. Sexual side effects often persist and are the most common reason patients ask to switch.

Other Antidepressant Classes

• SNRIs (venlafaxine, duloxetine). Useful when depression coexists with chronic pain or neuropathy. Duloxetine has an FDA indication for diabetic peripheral neuropathy and fibromyalgia.
• Bupropion (Wellbutrin). An atypical that affects dopamine and norepinephrine. Does not cause sexual dysfunction or weight gain — often added or substituted for these reasons. Activating, so generally avoided in anxiety-dominant presentations or seizure-disorder histories.
• Mirtazapine (Remeron). Sedating and appetite-stimulating at low doses (7.5–15 mg). Useful when depression presents with insomnia and weight loss.
• Trazodone. Rarely used as monotherapy at antidepressant doses (150–300 mg) due to sedation, but often added at low doses (25–100 mg) for sleep.

Lifestyle and Behavioral Factors

None of the following replaces appropriate therapy or medication for moderate-to-severe depression, but each has measurable effects in clinical trials:

• Regular exercise. 30 minutes of moderate aerobic activity 3–5 times per week produces antidepressant effects roughly comparable to medication for mild depression.
• Sleep regulation. Insomnia and depression feed each other; treating sleep often improves mood.
• Alcohol reduction. Alcohol is a depressant and worsens both mood and sleep, even at moderate intake.
• Sunlight and social connection. Both modestly antidepressant. Isolation predicts relapse.
• Bright light therapy. Especially effective for seasonal patterns; mornings, 10,000-lux box for 30 minutes.

When Telehealth Is Appropriate

Telehealth is well-suited for mild-to-moderate depression management. A visit at Innocre typically covers:

• Standardized screening (PHQ-9) for severity and tracking
• History, including any prior medication trials and what worked or did not
• Suicidality assessment
• Discussion of therapy vs. medication vs. both, based on your preferences and severity
• If medication is appropriate, starting an SSRI or alternative with a clear titration plan
• Referral to a local therapist or telehealth therapy platform
• Follow-up at 2 and 6 weeks to assess response

When You Need an In-Person Visit Instead

Telehealth is not the right setting for every patient with depression. Seek in-person care if:

• You are having active suicidal thoughts with a plan or intent
• You have psychotic features (hallucinations, delusions)
• You have severe functional impairment (unable to work, care for yourself, or eat)
• You have bipolar disorder — SSRIs without a mood stabilizer can precipitate mania
• You have not responded to two adequate trials of medication (treatment-resistant depression may benefit from psychiatry referral, possibly for ketamine, TMS, or ECT consultation)
• You are pregnant or postpartum and starting a new medication — ideally with an OB or perinatal psychiatrist

Frequently Asked Questions